ReviewCancers2023

Breaking the Invisible Barriers: Unleashing the Full Potential of Immune Checkpoint Inhibitors in Oncogene-Driven Lung Adenocarcinoma.

Hoi-Hin Kwok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.